Total recall of unregistered Vimpat Tablets 50mg and 100mg (with photo)

The Department of Health today (August 14) instructed Orient Europharma Company Limited, a licensed wholesaler, to conduct a total recall of Vimpat Tablets 50mg and 100mg from the market as Orient Europharma had imported and distributed the unregistered version of the products containing soya lecithin coating instead of the registered version.